Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Upstox is not in a rush to go public, with the brokerage prioritising profitability and business diversification amid a tougher...
Victoria’s Secret is betting that the generation raised on body positivity—not “heroin chic”—is ready to reclaim its famously glittering runway....
The urgent investigation into the apparent kidnapping of 84-year-old Nancy Guthrie continued Sunday, a week after the mother of “Today” show host Savannah...
As the search for Nancy Guthrie extends into a second week, more details are emerging about an alleged ransom note...
By looking back over the past half-decade or so, investors can learn a lot about changing macroeconomic and industry forces...
Sebi on Monday proposed a sharp reduction in the minimum investment required from individual investors in social impact funds to...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
